See the DrugPatentWatch profile for tigecycline

Yes, Tigecycline is an antibiotic that is used to treat various bacterial infections, and it is effective against drug-resistant bacteria [1]. One such bacteria sensitive to Tigecycline is Acinetobacter baumannii, which is a Gram-negative bacterium that can cause severe infections, including pneumonia, bloodstream infections, and meningitis [2].

According to DrugPatentWatch.com, Tigecycline is a glycylcycline antibiotic that is effective against a broad range of bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE) [3]. However, the overuse and misuse of Tigecycline and other antibiotics have led to the emergence of antibiotic-resistant bacteria, which poses a significant public health threat [4].

In summary, Acinetobacter baumannii is a bacteria that is sensitive to Tigecycline, which is a broad-spectrum antibiotic used to treat various bacterial infections. The overuse and misuse of Tigecycline and other antibiotics have led to the emergence of antibiotic-resistant bacteria, which is a significant public health concern.

Sources:

1. Mayo Clinic. (2021). Tigecycline (Oral Route). Retrieved from <https://www.mayoclinic.org/drugs-supplements/tigecycline-oral-route/description/drg-20066821>.
2. Centers for Disease Control and Prevention. (2021). Acinetobacter. Retrieved from <https://www.cdc.gov/acinetobacter/index.html>.
3. DrugPatentWatch.com. (2021). Tigecycline. Retrieved from <https://www.drugpatentwatch.com/drugs/tigecycline>.
4. World Health Organization. (2019). Antibiotic resistance. Retrieved from <https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance>.